Pierce Joanna Garcia, Mithal Divakar S
Division of Neurology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL.
Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL.
Pediatr Neurol Briefs. 2020 Mar 12;34:8. doi: 10.15844/pedneurbriefs-34-8.
Investigators for the FAiRE DS Study Group assessed the efficacy and safety of Fenfluramine for treating seizures in patients less than 18 y.o. with Dravet Syndrome in an international double-blind, placebo-controlled clinical trial. A total of 119 patients (mean age 9.0 y, 54% male) were enrolled in the study.
FAiRE DS研究小组的研究人员在一项国际双盲、安慰剂对照临床试验中,评估了氟苯丙胺治疗18岁以下患有德雷维特综合征患者癫痫发作的疗效和安全性。共有119名患者(平均年龄9.0岁,54%为男性)参与了该研究。